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Introduction
Some strains of Gram-positive and Gram-negative 
bacteria have the ability to produce bacteriocins. Bacterio-
cins are ribosomaly synthesised antimicrobial peptides 
that generally inhibit the growth of closely related mi-
crobes, with a narrow spectrum of activity (1). Many bac-
teriocins from Gram-positive bacteria show inhibitory ac-
tivity not only within the species of the producer, but also 
against species or genera diff erent from the bacteriocin 
producer, including foodborne pathogens and spoilage 
microorganisms such as Listeria monocytogenes, Bacillus ce-
reus, Staphylococcus aureus and Clostridium tyrobutyricum 
(2). Based on structure, mode of action and biochemical 
and genetic characteristics, bacteriocins from Gram-po-
sitive bacteria can be divided into four main groups: (i) 
lantibiotics, (ii) non-modifi ed heat-stable bacteriocins, (iii) 
large heat-stable bacteriocins, and (iv) cyclic bacteriocins 
(3). Bacteriocins produced by lactic acid bacteria (LAB) 
are of special interest for many reasons, one of the most 
important being that they are generally regarded as safe 
(GRAS) for human consumption, since they are found or 
used in fermented food and feed products (3). LAB are 
used as starter cultures for a wide variety of fermented 
dairy and meat products. Among them, Lactococcus lactis 
strains are the most commonly used by the dairy industry 
for the manufacture of diff erent types of cheese (4). Bacte-
riocins from all four main groups have been isolated from 
diff erent strains of L. lactis. In the last two decades, the 
interest in the application of bacteriocinogenic LAB and 
their bacteriocins to food preservation has increased. Dur-
ing this period, several new bacteriocins have been char-
acterised, but only nisin and pediocin are permitt ed for 
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application in the production of cheese and some meat 
products (5). The chances of isolating bacteriocinogenic 
strains from cheese produced from raw milk have in-
creased since this is a natural environment for the growth 
and development of LAB. In traditionally manufactured 
homemade cheese, without the use of commercial starter 
cultures, non-starter lactic acid bacteria (NSLAB) usually 
become the dominant cheese microbiota that contribute 
to the texture, fl avour and quality of the product (6). The 
exact role of NSLAB strains is not fully clear, but they cer-
tainly infl uence cheese ripening. On the other hand, they 
can be the source of a variety of diff erent new, and some 
old preserved, properties of LAB, which the industrial 
strains have lost over years of use. Besides the production 
of antimicrobial substances, aggregation ability could 
play the main role in the adhesion of bacteria, colonisa-
tion ability and coaggregation with other bacterial strains 
(7,8). The only aggregation-promoting factor described so 
far in lactococci is the one characterised in L. lactis ssp. 
lactis BGKP1 strain (9). The aim of this work is the isola-
tion of natural strains of lactococci from homemade 
cheese, manufactured without using a starter culture, 
with the ability to produce bacteriocin(s) and to aggre-
gate, in order to identify a strain with new properties.
Materials and Methods
Isolation of bacteriocin-producing lactococci
The bacterial strains used in this study are listed in 
Table 1 (10–13). Semi-hard cheese was produced in a tra-
ditional way in the village of Žanjic, Montenegro, without 
the addition of any starter cultures. Cheese sample (20 g) 
was homogenised with 180 mL of peptone water (0.1 % 
by mass per volume), submitt ed to serial tenfold dilutions 
in peptone water and spread on the surface of M17 plates 
(Merck GmbH, Darmstadt, Germany) supplemented with 
(by mass per volume): glucose 0.5 % and GM17 agar 1.5 
%. Aft er aerobic incubation at 30 °C for 48 h, colonies 
were randomly selected and transferred to GM17 broth 
and incubated at 30 °C. For detection of bacteriocin activ-
ity, an agar well diff usion assay was used (14). Lactococcus 
lactis ssp. lactis BGMN1-596 was used as an indicator 
strain. Aliquots (50 μL) of the supernatant of 15-hour 
overnight cultures of tested strains were poured into the 
wells (Ø 5 mm) made in GM17 soft  agar. To confi rm the 
production of antimicrobial compounds of proteinaceous 
nature, crystals of pronase E (P5147, Sigma-Aldrich Che-
mie GmbH, Taufk irchen, Germany), proteinase K (P8044, 
Sigma-Aldrich Chemie GmbH), trypsin (T1005, Sigma- 
-Aldrich Chemie GmbH) and pepsin (P7000, Sigma-Al-
drich Chemie GmbH) were placed close to the edge of the 
wells. The plates were incubated overnight at 30 °C. A 
clear zone of inhibition around the well, but not near the 
pronase E, proteinase K, trypsin and pepsin, was taken as 
a positive signal for bacteriocin production. For further 
work, one strain, designated BGBM50, was chosen.
Molecular determination of the bacteriocin producer
Preliminary determination of strain BGBM50 was 
performed with classical microbiological and biochemical 
techniques. Fermentation ability was determined by API 
50CHL (API System S.A., bioMérieux, Marcy l’Etoile, 
France). Total DNA from pure cultures was extracted by 
the method of Hopwood et al. (15), modifi ed as follows: a 
pellet of log culture (A600 nm=0.6–0.8) was washed in 0.5 mL 
of TEN buff er (50 mM Tris-HCl, pH=8, 10 mM EDTA, 
pH=8, 50 mM NaCl) and resuspended in 0.5 mL of buff er 
(0.5 M sucrose, 40 mM ammonium acetate and 10 mM 
magnesium acetate, pH=7). The concentration of lyso-
zyme was 8 mg/mL. Cells were incubated at 37 °C for 30 
Table 1. Bacterial strains and plasmids
Bacterial strain Description Source or reference
Lactococcus lactis 
BGBM50 Natural isolate from semi-hard cheese, Bac+, Bacim, Agg+/– This work
BGBM50-8 Derivative of BGBM50, Bac+,Bacim, Agg+/– This work
BGBM50-34 Derivative of BGBM50-8, Bac+, Bacim, Agg+ This work
BGBM50-11 Derivative of BGBM50-8, Bac+, Bacim, Agg+/– This work
BGBM50-13 Derivative of BGBM50-11, Bac+, Bacim, Agg+/– This work
BGBM50-14 Derivative of BGBM50-11, Bac–, Bacs, Agg+/– This work
BGBM50-25 Derivative of BGBM50-11, Bac+, Bacim, Agg+/– This work
BGBM50-62 Derivative of BGBM50-11, Bac+, Bacim, Agg+/– This work
BGMN1-5 Natural isolate from semi-hard cheese, Bac+(lactococcin B, lsbB producer) Bacim, Agg+ (10)
BGMN1-501 Derivative of BGBM1-5, Bac+ (lactococcin B producer) lacBim (10)
BGMN1-596T Derivative of BGBM1-5, Bac+ (lsbB producer), Bacim, Agg– (10)
MG7284/pAZIL-lsbB Derivate of MG7284 with pAZIL-lsbB, (lsbB producer) lsbBim (11)
BGMN1-596 Plasmid-free derivative of BGMN1-5, Prt-, Bacim, Agg– (10)
BGBU1-4 Natural isolate from semi-hard cheese, Bac+ (unknown bacteriocin producer), Bacim (12)
BGSM1-19 Natural isolate from semi-hard cheese, Bac+ (lactin RM, lactococcin B producer), Bacim (13)
Bac+=bacteriocin producer, Bac–=non-bacteriocin producer, Bacs=sensitivity to bacteriocin, Bacim=immunity to bacteriocin, 
Agg+=aggregation, Agg+/–=slow aggregation
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min, and then 250 μL of 2 % sodium dodecyl sulphate 
(SDS) were added and vortexed for 1 min. Following cell 
lysis, phenol-chloroform extraction was performed until 
the solution was almost protein free. DNA was concen-
trated with 3 M sodium acetate, pH=4.8 (1/10 of total vol-
ume) and isopropanol (the same volume as the DNA wa-
ter solution). Aft er centifugation (13 000 rpm for 5 min), 
the pellet was washed with ethanol (75 %, 1 mL), centri-
fuged again (13 000 rpm for 5 min), air dried and resus-
pended in 50 μL of double distilled water. Final species 
identifi cation based on 16S rDNA sequencing was per-
formed as described previously by Golic et al. (16). The 
16S rDNA was sequenced (Macrogen, Amsterdam, The 
Netherlands) with UNI16SF and UNI16SR (17) primers.
Biochemical characterisation of bacteriocin produced by 
L. lactis ssp. lactis BGBM50
Cell-free culture supernatant of strain BGBM50 was 
incubated for 15 min at 40, 60, 80 and 100 °C. Then, the 
samples were cooled to room temperature and the re-
maining bacteriocin activity was determined. To deter-
mine the eff ect of pH on bacteriocin activity, the pH of the 
bacteriocin samples was adjusted to pH=2, 7 and 10 with 
1 M HCl or 1 M NaOH. Samples were incubated for 1 h at 
30 °C and bacteriocin activity was determined using the 
agar well diff usion test. The supernatant of the non-bacte-
riocin-producing strain BGMN1-596 was pretreated in the 
same way as the bacteriocin sample and used as a control 
to eliminate the eff ect of pH alone on the growth of the 
indicator strain.
Search for bacteriocin-encoding genes by polymerase 
chain reaction
Genes coding for the most common bacteriocins pro-
duced by L. lactis strains were sought by specifi c PCR 
primers (Table 2; 18,19). All amplifi cation reactions were 
conducted under standard conditions at an annealing 
temperature of 50 °C. The PCR products were purifi ed, 
sequenced (Macrogen) and analysed using BLAST algo-
rithm (National Center for Biotechnology Information, 
National Library of Medicine, Bethesda, MD, USA).
Plasmid curing experiments
Plasmid curing was achieved by growing the cells in 
the presence of novobiocin at sublethal temperature (20). 
Briefl y, prewarmed GM17 broth (39 °C) containing novo-
biocin (8 μg/mL) was inoculated with 103 cells per mL. Af-
ter 2 h of incubation, the cells were collected by centrifu-
gation and resuspended in the same volume of 
prewarmed novobiocin containing GM17 broth to avoid a 
bacteriocin-killing eff ect on the cured (Bac–Bacs) cells. The 
same step was repeated ten times and the aliquots (0.1 
mL) were then plated onto GM17 agar plates, which were 
then incubated at 30 °C for 48 h. To detect Bac–Bacs deriva-
tives, Petri plates were overlaid with a reconstituted 
GM17 soft  agar containing indicator cells BGMN1-596 
and incubated overnight at 30 °C. Colonies that lost the 
ability to inhibit the indicator strain were taken from the 
original master plate and used as indicator strains for re-
checking their Bac–Bacs phenotype. Plasmid profi le and 
pulsed fi eld gel electrophoresis (PFGE) were used to con-
fi rm that the obtained derivatives, aft er plasmid curing 
experiments, originated from strain BGBM50. Incorpora-
tion of lactococcal bacterial cells into agarose blocks, re-
striction enzyme treatment and PFGE were conducted as 
described previously (21).
Visual aggregation assay
Among 50 selected isolates from homemade cheese 
in the village Žanjic, Montenegro, the strains that exhibit-
ed aggregation ability were screened by a visual assay. 
Aggregation received positive scores when clearly visible 
sand-like particles, formed by aggregated cells, gravitat-
ed to the bott om of the tube, forming a precipitate and 
leaving a clear supernatant.
Results
Identifi cation of bacteriocin-producing isolates
Fift y randomly selected colonies, isolated using stan-
dard procedures for the isolation of lactic acid bacteria, 
were collected from semi-hard homemade cheese manu-
factured in the village of Žanjic and subjected to bacterio-
cin testing. Two isolates showing inhibitory activity of the 
growth of indicator strain Lactococcus lactis ssp. lactis 
BGMN1-596 were identifi ed according to microbiological 
techniques, the API50 CHL system and by sequencing of 
the genes for 16S rRNA. According to these results, iso-
late BGBM50 showed the highest zone of inhibition and 
aggregation phenotype. It was identifi ed as Lactococcus 
lactis ssp. lactis and chosen for further study.
Table 2. Primers used throughout this study
Name Sequence (5`-3`) Bacteriocin gene Reference
Lact481-F CCAATGTCATTGCATCTGCAC Lacticin 481 gene (18)
Lact481-R GTCCTTATGTTGCTATTCATC Lacticin 481 gene (18)
Lcn972-F TTGTAGCTCCTGCAGAAGGAACATGG Lactococcin 972 gene (19)
Lcn972-R GCCTTAGCTTTGAATTCTTACCAAAAG Lactococcin 972 gene (19)
LactGQ-F GAAAGAATTATCAGAAAAAG Lactococcin G and Q genes (18)
LactGQ-R CCACTTATCTTTATTTCCCTCT Lactococcin G and Q genes (18)
Lact3147-F GTCTTTGTGTTGTTTGGAGATG Lacticin 3147 gene (18)
Lact3147-R CAACTCCCGAAATAAATCATCG Lacticin 3147 gene (18)
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Bacteriocin production and its biochemical 
characterisation
The inhibitory substance produced by isolate BGBM 
50 was temporarily designated as bacteriocin BacBM50. It 
was observed that the production of bacteriocin by strain 
BGBM50 in GM17 medium depended on the growth phase 
and reached a maximal plateau when the culture entered 
the late exponential phase (data not shown). Bacteriocin 
BacBM50 is a heat-stable molecule; its antimicrobial activ-
ity was not aff ected by treatment at 100 °C for 30 min, but 
aft er 60 min, the activity was completely abolished. Pres-
ent in the cell-free supernatant of the producer strain, bac-
teriocin BacBM50 retained antimicrobial activity in a pH 
range between 1 and 12, with maximum activity observed 
between pH=5 and 7. The inhibitory activity on the growth 
of sensitive indicator cells was eliminated by treatment 
with proteolytic enzymes such as pepsin, trypsin, pronase 
E and proteinase K.
Targeting the bacteriocin-encoding genes by PCR
PCR analysis was undertaken using gene-specifi c 
primers to determine genes of the most common lactococ-
cal bacteriocins. Positive amplifi cation was obtained only 
when gene-specifi c primers for the genes encoding bacte-
riocin lactococcin G were used. The amplifi ed fragment 
was sequenced and it confi rmed that strain BGBM50 pro-
duces lactococcin G. Interestingly, a cross-immunity test 
with Lactococcus lactis LMG 2081 strain, a producer of lac-
tococcin G (22), revealed that strain BGBM50 does not in-
hibit the growth of strain LMG 2081. On the contrary, 
strain LMG 2081 inhibited the growth of BGBM50 indi-
cating that strain LMG 2081 produces additional bac te rio-
cin(s). In order to determine the antimicrobial spectrum 
of bacteriocin lactococcin G, cross-immunity tests with 
other lactococcal bacteriocin-producing strains were per-
formed and the results are presented in Table 3.
Localisation of the genes coding for lactococcin G 
production
Plasmid curing was performed to check whether the 
genes coding for bacteriocin synthesis and immunity are 
located on plasmids. In plasmid curing experiments, the 
derivative BGBM50 that lost its immunity to bacteriocin 
and the ability of synthesis was obtained. The diff erence 
in bacteriocin phenotypes of plasmid-cured derivatives 
was determined by using the agar well diff usion assay. 
Two groups of bacteriocinogenic derivates were obtained. 
Among the cured derivatives it was noticed that one, 
BGBM50-11, showed much smaller zone (2 mm) of inhibi-
tion compared to that of the parental strain (5 mm). The 
plasmid profi le analysis revealed that derivative BGBM- 
50-11 lost some plasmids (Fig. 1), but it was not possible 
to make any correlation with reduced bacteriocin activity. 
However, one of the most interesting derivatives was 
found inside the second group. BGBM50-14 did not pro-
duce lactococcin G, but was sensitive to it. PFGE analyses 
revealed that BGBM50-14 lost a plasmid of at least 140 kb 
(pBM140), indicating that the genes coding for bacteriocin 
lactococcin G synthesis and immunity are located on 
plasmid pBM140 in strain BGBM50 (Fig. 2). The appear-
ance of one extra band in PFGE macrorestriction analysis 
of the derivatives compared to the wild-type strain, with-
out changes in the sizes or patt ern of other restriction 
fragments, strongly indicates that the extra fragment be-
longs to extrachromosomal element (plasmid). In cases 
when restriction enzymes with unusual appearance are 
used for macrorestriction analysis, and good distribution 
of fragments on the PFGE gel is obtained, it can be postu-
lated that the extra fragments observed represent a com-
plete plasmid (20).
Strain BGBM50 produces aggregation factor similar to 
AggL
Among cured derivatives we noticed that derivative 
BGBM50-34 had enhanced aggregation ability compared 
to the wild-type strain, but it retained bacteriocin produc-
tion ability. Since AggL is a known lactococcal aggrega-
tion-promoting factor (9), we subjected both wild-type 
strain BGBM50 and derivative BGBM50-34 to Southern 
hybridisation experiments with an aggL gene probe. It 
was found that the gene for aggregation-promoting factor 
Table 3. Antimicrobial activity of bacteriocin-producing Lacto-
coccus lactis strains
             Bac producer












































BGBM50 – + – – – + –
BGMN1-5 + – – – – + –
BGMN1-501 + + – + + + +
BGMN1-596T + + + – – + +
MG7284/pAZIL-lsbB + + – – – + +
BGBU1-4 + + – – – – +
BGSM1-19 – – – – – + –
BGMN1-596 + + + + + + +
Screening of L. lactis strains for antimicrobial activity using agar 
well diff usion method was performed in triplicate
+=an inhibition zone sensitive to protease; –=without a zone
Fig. 1. Plasmid profi les of cured derivates of Lactococcus lactis 
BGBM50. Lane 1=BGBM50, lane 2=BGBM50-8, lane 3=BGBM50-
-34, lane 4=BGBM50-11, lane 5=BGBM50-13, lane 6=BGBM50-14, 
lane 7=BGBM50-25, lane 8=BGBM50-62
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in strain BGBM50 shares high identity with the known 
aggL gene. It is interesting that no diff erences in size and 
intensity of hybridisation signals were observed between 
BGBM50 and derivative BGBM50-34 (data not shown), in-
dicating that some small changes that aff ect the regula-
tion of aggL gene expression occurred during curing ex-
periment.
Discussion
Lactic acid bacteria (LAB) inhabit diff erent natural 
niches, ranging from plants to mammalian cavities in 
which they live among a wide variety of diff erent bacte-
ria. In order to adapt to diff erent environments and bacte-
rial species they encounter, LAB synthesise various com-
pounds, among which are bacteriocins, ribosomally 
synthesised antimicrobial peptides. Most of the studies 
on the biotechnological application of diverse bacterio-
cins have focused on their use as food preservatives, and 
more recently as preservatives for pharmaceutical indus-
tries and as alternatives to antibiotics. An emerging prob-
lem all over the world is the quick spread of multidrug 
resistance among diff erent bacterial species. There is an 
urgent need for a new approach to the treatment of these 
bacteria. Synergy between antibiotics and diff erent anti-
microbial peptides as well as bacteriocins is becoming 
a new area of scientifi c research (23). For that reason, 
there is a permanent need to search for new LAB strains 
that synthesise bacteriocins with greater potency. Sources 
of such LAB strains may include various milk products. 
For the present research, we chose cheese manufactured 
without the addition of known strains, in order to isolate 
new strains with bacteriocin production ability. Among a 
number of isolated bacteriocin-producing strains ob-
tained in previous research (21), BGBM50, with the high-
est potency, was used for further analysis. Biochemical 
characterisation of BacBM50 showed similar biochemical 
characteristics to other previously characterised bacterio-
cins produced by lactococcal strains (10,14,24). The quick-
est approach to the detection of new bacteriocin genes 
was a combination of a few powerful techniques: search-
ing for new genes for bacteriocin synthesis by PCR with 
specifi c primers for known bacteriocin genes, plasmid 
curing, and cross-immunity test with known bacteriocin 
producers. It has been demonstrated that strain BGBM50 
produces bacteriocin lactococin G, for which synthesis 
genes are located on a big plasmid of at least 140 kb. The 
location of genes for bacteriocin production on such big 
plasmid has been detected in L. lactis ssp. lactis bv. diacet-
ylactis S50 (20). It is interesting that strain BGBM50 pro-
duces only lactococcin G, in contrast to LMG 2081, and 
can be used in cross-immunity test as a producer of only 
one bacteriocin. Isolation and characterisation of strain 
BGBM50 as a producer of only one bacteriocin (lactococ-
cin G) enabled us to establish that the strain LMG 2081 
produces more than one bacteriocin, which has not been 
known until now. In addition, the real inhibitory spectra 
of bacteriocin producers can be determined only when 
we are sure that a strain produces only one inhibitory 
compound. Moreover, strain BGBM50 showed slow ag-
gregation phenotype, with a high identity with the one 
determined for the L. lactis ssp. lactis BGKP1 strain (9), 
which was increased in mutant BGBM50-34. This was 
most probably due to the infl uence of curing treatment on 
the genes for the regulation of DNA elements responsible 
for transcription, not for plasmid replication, or it could 
be that aggL gene somehow att enuated in the wild-type 
strain. This work has demonstrated the feasibility of stud-
ies aimed at discovering new strains that can express 
multiple traits important for probiotic activity and bio-
preservation of foods such as the synthesis of bacteriocins 
and aggregation-promoting factors. Moreover, L. lactis 
strains from traditional types of cheese are important 
source of new properties, which are lost or changed in the 
industrial strains used for decades in food production.
Conclusions
In conclusion, a bacteriocin-producing strain, Lacto-
coccus lactis ssp. lactis BGBM50, was selected from a col-
lection of 50 strains. All strains originated from tradition-
al semi-hard cheese made from starter-free raw milk. This 
strain produced lactococcin G, which we characterised 
both on molecular and biochemical level. According to 
these results, we propose this bacteriocin for potential use 
as a biopreservative in the food industry. Moreover, a de-
rivative of this strain expresses increased aggregation 
phenotype, indicating its probiotic potential.
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Fig. 2. SmaI PFGE restriction patt ern of Lactococcus lactis BGBM- 
50 and its plasmid cured derivates. Lane 1=BGBM50, lane 2=BGBM- 
50-8, lane 3=BGBM50-34, lane 4=BGBM50-11, lane 5=BGBM50- 
-13, lane 6=BGBM50-14, lane 7=BGBM50-25, lane 8=BGBM50-62. 
Arrows indicate SmaI DNA fragments missed in cured deriva-
tives
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